TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2024 | ₹2,824 Cr |
Mar2023 | ₹2,431 Cr |
Mar2022 | ₹2,480 Cr |
Mar2021 | ₹2,170 Cr |
Mar2020 | ₹1,976 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2,824 Cr | 16.15 | |
Mar2023 | ₹2,431 Cr | -1.97 | |
Mar2022 | ₹2,480 Cr | 14.27 | |
Mar2021 | ₹2,170 Cr | 9.81 | |
Mar2020 | ₹1,976 Cr | - |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹110,008.8 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 2.3% |
-0.5% |
13.8% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses